June 10, 2020 / 5:37 AM / a month ago

BRIEF-Xlife Says Prostatecarcinoma.Ai Offers Medical Advantages

June 10 (Reuters) - XLIFE SCIENCES AG:

* THE PROJECT COMPANY FUSE-AI GMBH REACHES ANOTHER MILESTONE BY DEVELOPING PROSTATECARCINOMA.AI

* RECENTLY COMPLETED DEMONSTRATOR PROVES THAT PARTIAL ASPECTS RELEVANT FOR PROSTATE CANCER DIAGNOSIS IN PROSTATE RECOGNITION AND LESION DETECTION ARE POSSIBLE Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below